CA Stock MarketDetailed Quotes
METX ME Therapeutics Holding Inc
- 3.710
- 0.0000.00%
15min DelayMarket Closed Jun 26 14:40 ET
93.45MMarket Cap-23782P/E (TTM)
0.000High0.000Low0Volume0.000Open3.710Pre Close0.00Turnover7.00052wk High0.00%Turnover Ratio25.19MShares0.05052wk Low-0.156EPS TTM40.97MFloat Cap7.000Historical HighLossP/E (Static)11.04MShs Float0.050Historical Low-0.277EPS LYR0.00%Amplitude--Dividend TTM57.08P/B1Lot Size--Div YieldTTM
ME Therapeutics Holding Inc Key Stats
Quarterly+Annual
YOY
| (Q3)May 31, 2024 | (Q2)Feb 29, 2024 | (Q1)Nov 30, 2023 | (FY)Aug 31, 2023 | (Q4)Aug 31, 2023 | (Q3)May 31, 2023 | (Q2)Feb 28, 2023 | (Q1)Dec 31, 2022 | (FY)Aug 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | |||||||||
| Gross profit | |||||||||
| Operating expense | -1.28%509.86K | 310.29%145.07K | 475.22%346.76K | 624.06%977.37K | 389.67K | 516.45K | 35.36K | 60.28K | 134.98K |
| Selling and administrative expenses | -14.95%418.31K | 91.70%63.73K | 396.55%299.34K | 877.06%950.21K | --389.43K | --491.85K | --33.24K | --60.28K | --97.25K |
| -General and administrative expense | -14.95%418.31K | 91.70%63.73K | 396.55%299.34K | 877.06%950.21K | --389.43K | --491.85K | --33.24K | --60.28K | --97.25K |
| Research and development costs | 383.55%118.9K | 3,769.12%81.33K | --66.83K | -50.40%27.12K | --225 | --24.59K | --2.1K | ---- | --54.67K |
| Depreciation amortization depletion | -16.67%10 | -15.38%11 | --9 | -19.67%49 | --12 | --12 | --13 | ---- | --61 |
| -Depreciation and amortization | -16.67%10 | -15.38%11 | --9 | -19.67%49 | --12 | --12 | --13 | ---- | --61 |
| Other operating expenses | ---27.36K | ---- | ---19.42K | ---- | ---- | ---- | ---- | ---- | ---17K |
| Operating profit | 1.28%-509.86K | -310.29%-145.07K | -475.22%-346.76K | -624.06%-977.37K | -389.67K | -516.45K | -35.36K | -60.28K | -134.98K |
| Net non-operating interest income (expenses) | 136.21%13.87K | 158.19%1.57K | 29.11%3.65K | 136.56%3.95K | 5.34K | 5.87K | -2.71K | 2.82K | -10.8K |
| Non-operating interest income | 136.21%13.87K | 671.57%1.57K | 29.11%3.65K | --11.41K | --5.34K | --5.87K | --204 | --2.82K | --0 |
| Non-operating interest expense | --0 | --0 | --0 | -30.91%7.46K | --0 | --0 | --2.91K | ---- | --10.8K |
| Other net income (expenses) | -5.55M | -2.56M | -2.98M | ||||||
| Special income (charges) | --0 | ---- | ---- | ---5.57M | ---- | ---- | ---- | ---- | --0 |
| -Less:Restructuring and mergern&acquisition | --0 | ---- | ---- | --5.57M | ---- | ---- | ---- | ---- | --0 |
| Other non-operating income (expenses) | ---- | ---- | ---- | --20K | --3M | ---2.98M | ---- | ---- | ---- |
| Income before tax | 85.81%-495.99K | -276.99%-143.49K | -497.14%-343.11K | -4,372.64%-6.52M | -2.95M | -3.49M | -38.06K | -57.46K | -145.78K |
| Income tax | |||||||||
| Earnings from equity interest net of tax | |||||||||
| Net income | 85.81%-495.99K | -276.99%-143.49K | -497.14%-343.11K | -4,372.64%-6.52M | -2.95M | -3.49M | -38.06K | -57.46K | -145.78K |
| Net income continuous operations | 85.81%-495.99K | -276.99%-143.49K | -497.14%-343.11K | -4,372.64%-6.52M | ---2.95M | ---3.49M | ---38.06K | ---57.46K | ---145.78K |
| Noncontrolling interests | |||||||||
| Net income attributable to the company | 85.81%-495.99K | -276.99%-143.49K | -497.14%-343.11K | -4,372.64%-6.52M | -2.95M | -3.49M | -38.06K | -57.46K | -145.78K |
| Preferred stock dividends | |||||||||
| Other under preferred stock dividend | |||||||||
| Net income attributable to common stockholders | 85.81%-495.99K | -276.99%-143.49K | -497.14%-343.11K | -4,372.64%-6.52M | -2.95M | -3.49M | -38.06K | -57.46K | -145.78K |
| Diluted earnings per share | 86.74%-0.02 | -509.01%-0.01 | -303.39%-0.01 | -4,299.75%-0.2767 | -0.1251 | -0.1508 | -0.0016 | -0.0025 | -0.0063 |
| Basic earnings per share | 86.74%-0.02 | -509.01%-0.01 | -303.39%-0.01 | -4,299.75%-0.2767 | -0.1251 | -0.1508 | -0.0016 | -0.0025 | -0.0063 |
| Dividend per share | |||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
%Chg